New Method To Diagnose Hereditary Breast And Ovarian Cancer

[News]

Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has proved very effective...

More... (http://www.medicalnewstoday.com/releases/255056.php)